ClinicalTrials.gov
ClinicalTrials.gov Menu

Idiopathic Pulmonary Fibrosis Registry for Future Studies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00815711
Recruitment Status : Unknown
Verified August 2014 by Clay Marsh MD, Ohio State University.
Recruitment status was:  Recruiting
First Posted : December 30, 2008
Last Update Posted : August 22, 2014
Sponsor:
Information provided by (Responsible Party):
Clay Marsh MD, Ohio State University

Brief Summary:
To establish a registry of patients for future studies of Inflammation in Interstitial Lung Disease/Idiopathic Pulmonary Fibrosis.

Condition or disease
Lung Disease, Interstitial Idiopathic Pulmonary Fibrosis

Detailed Description:
To establish a framework in which biologic samples and physiologic measures from patients with IPF can be longitudinally collected and evaluated. Having a bank of samples that are correlated with physiologic measures that follow patients through their course will allow the following proposed studies as well as future investigations to be efficiently carried out.

Study Type : Observational
Estimated Enrollment : 84 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Inflammation in Interstitial Lung Disease/Idiopathic Pulmonary Fibrosis
Study Start Date : December 2008
Estimated Primary Completion Date : January 2015
Estimated Study Completion Date : January 2015





Primary Outcome Measures :
  1. Framework [ Time Frame: 7 + years ]
    To establish a framework in which biologic samples and physiologic measures from patients with IPF can be longitudinally collected and evaluated


Biospecimen Retention:   Samples With DNA
blood serum BAL fluid lung biopsy


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
primary care clinic
Criteria

Inclusion Criteria:

  • any patient referred to the Interstitial Lund Disease clinic who is undergoing evaluation and or treatment for a new diagnosis of ILD. This can include patients referred for presumed pulmonary fibrosis/interstitial pneumonitis (IPF, UIP, NSIP), sarcoidosis, hypersensitivity pneumonitis, cryptogenic organising pneumonia, drug-induced, or other idiopathic ILDs.

Exclusion Criteria:

  • pregnancy
  • inability to follow study requirements

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00815711


Contacts
Contact: Janice E Drake, CRTT 614-688-2287 janice.drake@osumc.edu
Contact: Sharon T Cheung, BS 614-366-2258 sharon.cheung@osumc.edu

Locations
United States, Ohio
The Ohio State University Recruiting
Columbus, Ohio, United States, 43210
Contact: Janice E Drake, CRTT         
Sub-Investigator: James N Allen, MD         
Sub-Investigator: Nitin Y Bhatt, MD         
Sub-Investigator: Christopher Baran, PhD         
Sponsors and Collaborators
Clay Marsh MD
Investigators
Principal Investigator: Clay B Marsh, MD Ohio State University

Responsible Party: Clay Marsh MD, SR Assoc VP for Health Sciences Research, Vice Dean of Research for the College of Medicine, Executive Director of the Center for Personalized Health Care, Director of the Center for Critical and Respiratory Care, Ohio State University
ClinicalTrials.gov Identifier: NCT00815711     History of Changes
Other Study ID Numbers: 2007H0002
First Posted: December 30, 2008    Key Record Dates
Last Update Posted: August 22, 2014
Last Verified: August 2014

Keywords provided by Clay Marsh MD, Ohio State University:
IPF

Additional relevant MeSH terms:
Fibrosis
Lung Diseases
Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Idiopathic Interstitial Pneumonias
Lung Diseases, Interstitial
Pathologic Processes
Respiratory Tract Diseases